Here’s some more disturbing press relative to BPA!
As you all know, I have been a critic of how slowly the FDA has responded to the many concerns raised about BPA or Bisphenol A.
In an article by Genevra Pittman for Reuters Health on Tue Sep 18, 2012 titled Study links BPA, obesity in kids indicates that kids and teens that had higher levels of the chemical bisphenol A in their urine were more likely to be overweight or obese, in a new nationally-representative U.S. study.
In one of my recent posts titled A day late and a dollar short! The FDA announces no more BPA in Baby Bottles on July 19th of this year, I was critical of how long the government takes to make decisions that other countries have made more quickly. This is a perfect example of newer findings that continue to support the fact that the FDA should have acted faster regardless of whether or not more study continues to be required to support the study.
This issue should also raise a red flag for procurement knowledge workers that buying products for their customers includes much more than just sourcing the finished goods. As an example when sourcing private label products, the formulary for over the counter pain relief is important, but so is the formulary that goes into the packing. How often do your buyers and category managers focus on that?
If you want to make sure that the products you buy for resale are as safe as possible, please contact a SafeSourcing customer services representative.
We look forward to and appreciate your comments.